Delivery Order SPE2DB22D1202-SPE2DB24FVFP7
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,564,977,955 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the delivery of 4565877563 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $4,874.35, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of September 20, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award, valued at $1,116.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone prop HFA 110 mcg 12gm, a pharmaceutical product, with a completion date of January 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The $1,346.54 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 21, 2024. The contract has a completion date of June 24, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
This federal contract award, valued at $2,786.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of January 24, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $2,004.05 and a completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $1,642.32. This is a firm fixed price delivery order contract with a completion date of June 14, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4563693017 Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,101.29 and a completion date of February 20, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $1,831.96 firm-fixed-price contract is for the supply of Fluticasone Propionate HFA 110 MCG 12GM, a respiratory medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...